T. Rowe Price Health Sciences Fund (PRHSX)

Access innovative companies in a dynamic industry.

Call 866-349-5897 to speak to an investment specialist about the
Health Sciences Fund.

Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 07/31/2017
Volatility and Other Measures
as of 07/31/2017
Beta 1.06
0.43
Standard Deviation 16.28
Price/Earnings Ratio (Domestic) 20.7
Earnings Growth Rate (Domestic) 12.4
Turnover Rate 19.2
Median Market
Capitalization
$34,857.29 Million
Sector Diversification
as of 07/31/2017
% of Total Net Assets
Biotechnology 34.6%
Services 24.8%
Pharmaceuticals 18.1%
Products & Devices 15.4%
Life Sciences 6.9%
Miscellaneous 0.1%
10 Largest Holdings
Represents 32.13 % of Total Net Assets
View Holdings as of:
Alexion Pharmaceuticals
Allergan
Becton, Dickinson & Company
Cigna
Humana
Incyte
Intuitive Surgical
Stryker
UnitedHealth Group
Vertex Pharmaceuticals
As of 07/31/2017 the Health Sciences Fund had a total of 159 holdings.
See Glossary for additional details on all data elements.